First patients recruited into Ondine’s Steriwave ICU pilot study - BioTuesdays
1 Articles
1 Articles
First patients recruited into Ondine’s Steriwave ICU pilot study - BioTuesdays
Ondine Biomedical (LON:OBI) announced the initiation of patient recruitment for an intensive care unit (ICU) pilot study at Royal Columbian Hospital (RCH) in New Westminster, British Columbia. The company states that incorporating Ondine’s Steriwave nasal photodisinfection technology into ICU care could significantly expand its market. The investigator-initiated study (IIS), first announced 25 September 2024, was designed by Dr. Stephen Reynolds…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage